Dopamine gene variants in opioid addiction: comparison of dependent patients, nondependent users and healthy controls
Matthew Randesi1, Wim van den Brink2,3, Orna Levran1
1Laboratory of the Biology of Addictive Diseases, The Rockefeller University, 1230 York Ave, New York, NY 10065, USA.
Aim:
To determine whether specific dopaminergic system gene variants are associated with opioid dependence.
Patients & Methods:
Subjects included 153 healthy controls, 163 opioid exposed, but not dependent and 281 opioid dependent. Genotypes of 90 variants in 13 genes were examined.
Results:
The most significant results were obtained for DA β-hydroxylase variants, rs2073837 and rs1611131, which were associated with protection from addiction (q = 0.0172, 0.0415, respectively) and the functional TH variant, rs2070762, was associated with more risk (q = 0.0387). The three variants also showed a combined effect that remained significant after correction for multiple testing (pfinal = 0.0039).
Conclusion:
These data offer support that dopaminergic gene variants have a role in opioid dependence and warrant further study.
More Related Videos
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Dependence
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Opioid Receptors: Overview
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu


